Congress Blog

Getting it right on value frameworks

“Value” — especially in the context of healthcare and medicine — is a word that gets used so often these days, and in so many different ways, that it can be difficult to pin down exactly what it means – or should mean. In the debate over the...

Read More...

Will the FCC destroy television?

As technology evolves, the challenges facing television and digital media companies over maintaining ownership of creative content becomes ever more important. This issue is especially crucial for the growing numbers of independent media...

Read More...

Congress shouldn’t consider TPP during lame duck session

The Trans-Pacific Partnership (TPP) will be the largest free trade agreement in history, with 12 nations representing 40 percent of the global market. In this context, the potential impact on the economy, the environment and American jobs is huge...

Read More...

A reflection on too big to fail

Nearly eight years after the Great Recession, where unscrupulous lending practices brought our global economy to a breaking point, we’ve learned that the Big Banks have learned little since the meltdown and returned to business as usual.

...

Read More...

Mylan CEO should be ashamed of EpiPen prices

Last week the House Oversight and Government Reform Committee held a hearing on the skyrocketing price of life-saving Epinephrine Auto-Injectors, better known as the EpiPen. This hearing was especially important because EpiPens are predominantly...

Read More...

EMV: the cost of confusion

Oct. 1, 2016 marks the one-year anniversary since the chip-card, or EMV, deadline set by the major card brands went into effect. Prior to the deadline, the grocery industry spent more than five years...

Read More...

Pages